Clinical, histopathological and immunofluorescent findings of IgA nephropathy

Iranian Journal of Immunology

Volumn 8, Issue 2, 2011, Pages 104-110

  Tipu, Hamid Nawaz ^a   Ahmed, Tahir Aziz ^b   Bashir, Muhammad Mokarram ^b  

^a Combined Military Hospital Chunian Cantt ^*  (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

Glomerulonephritis; IgA Nephropathy; Immunofluorescence

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; FIBRINOGEN; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGE DISTRIBUTION; ANTIBODY LABELING; ARTICLE; CLINICAL FEATURE; FEMALE; FLUORESCENCE MICROSCOPY; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MORBIDITY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; SEX RATIO; STAINING;

EID: 80052828784     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol. 1968; 74:694-5.
2. Julian BA, Waldo FB, Rifai A, Mesteckey J. IgA nephropathy, the most common glomerulonephritis worldwide: a neglected disease in the United States? Am J Med. 1988; 84:129-32.
3. th ed. Blackwell science ltd; 2001.
4. th ed. United States: Lange Medical Books/McGraw-Hill Medical Publishing Division. 2003; 481-94.
5. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002; 347:738-48.
6. th ed. Churchill Livingstone/ Elsevier Limited. 2006; 455-518.
7. th ed. St Louis: MOSBY. 2005; 1163-359
8. Chandrika BK. IgA nephropathy in Kerala, India: A retrospective study. Indian J Pathol Microbiol. 2009; 52:14-6
9. Sharmin F, Khan BR, Rahman M, Rashid HU, Islam B, Kamal M, et al. IgA nephropathy in teaching hospitals of Dhaka. Bangladesh Medical Research Council Bulletin. 1997; 23:25-9.
10. Mitwalli AH, Al Wakeel J, Abu-Aisha H, Alam A, Al-Sohaibaini M, Tarif N, et al. Prevalence of glomerular diseases: King Khalid university hospital, Saudi Arabia. Saudi J Kidney Dis Transpl. 2000; 11:442-8.
11. Khan TN, Sinniah R, Naqvi SA, Lal M, Osmani M. IgA nephropathy in Pakistan. J Pak Med Assoc. 1990; 40:31-6.
12. Muzaffar S, Azad NS, Kayani N, Pervaz S, Ahmed A, Hasan SH. The frequency of IgA nephropathy at a single centre in Pakistan. J Pak Med Assoc. 2003; 53:301-5.
13. Noor M, Jamal SM, Mohammad W, Shah D. IgA nephropathy in North West Frontier province of Pakistan. Gomal J Med Sci. 2007; 5:62.
14. Maxwell PH, Wang Y. Genetic studies of IgA nephropathy. Nephron Exp Nephrol. 2006; 102:76-80.
15. Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, et al. IgA1 secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008; 118:629-39.
16. Chacko B, John GT, Neelakantan N, Korula A, Balakrishnan N, Kieubakaran NG, et al. Presentation, prognosis and outcome of IgA nephropathy in Indian adults. Nephrology. 2005; 10:496-503.
17. Mubarak M. IgA nephropathy: An update on pathogenesis and classification. JCPSP. 2011; 12:230-3.
18. Hricik DE, Chung-Park M, Sedor JR. Glomerulonephritis. N Engl J Med. 1998; 339:888-99.
19. Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998; 338:1202-11.
20. Moriyama T, Shimizu A, Takei T, Uchida K, Honda K, Nitta K. Characteristics of immunoglobulin A nephropathy with mesangial immunoglobulin G and immunoglobulin M deposition. Nephrology. 2010; 15:747-54.
21. Van Es LA. Pathogenesis of IgA nephropathy. Kidney International. 1992; 41:1720-9.
22. Wayatt RJ, Kanayama Y, Julian BA, Negoro N, Sugimoto S, Hudson EC, et al. Complement activation in IgA nephropathy. Kidney International. 1987; 31:1019-23.
23. Wayatt RJ, Julian BA. Activation of complement in IgA nephropathy. American Journal of Kidney Diseases. 1988; 12:437-42.
24. Floege J, Feehally J. IgA nephropathy: Recent developments. J Am Soc Nephrol. 2000; 11:2395-403.
25. Madaio MP, Harrington JT. The diagnosis of glomerular diseases. Arch Intern Med. 2001; 161:25-34.